Optimizing Dosing of Trastuzumab Deruxtecan in HER2 -Mutant Non-Small-Cell Lung Cancer: A Reminder That More Is Not Always Better.
Hui Jing HoeBenjamin J SolomonPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)